JP2023549814A5 - - Google Patents
Info
- Publication number
- JP2023549814A5 JP2023549814A5 JP2023528431A JP2023528431A JP2023549814A5 JP 2023549814 A5 JP2023549814 A5 JP 2023549814A5 JP 2023528431 A JP2023528431 A JP 2023528431A JP 2023528431 A JP2023528431 A JP 2023528431A JP 2023549814 A5 JP2023549814 A5 JP 2023549814A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- biological sample
- bischoline
- tetrathiomolybdate
- ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063113516P | 2020-11-13 | 2020-11-13 | |
| US63/113,516 | 2020-11-13 | ||
| US202163242722P | 2021-09-10 | 2021-09-10 | |
| US63/242,722 | 2021-09-10 | ||
| PCT/US2021/059239 WO2022104135A1 (en) | 2020-11-13 | 2021-11-12 | Methods of treating copper metabolism-associated diseases or disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023549814A JP2023549814A (ja) | 2023-11-29 |
| JP2023549814A5 true JP2023549814A5 (https=) | 2024-10-18 |
Family
ID=78844761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023528431A Pending JP2023549814A (ja) | 2020-11-13 | 2021-11-12 | 銅代謝関連疾患又は障害を治療する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230414654A1 (https=) |
| EP (1) | EP4243806A1 (https=) |
| JP (1) | JP2023549814A (https=) |
| CA (1) | CA3172751A1 (https=) |
| WO (1) | WO2022104135A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023023199A1 (en) * | 2021-08-17 | 2023-02-23 | Alexion Pharmaceuticals, Inc. | Methods of treating copper metabolism-associated diseases or disorders |
| WO2023038909A1 (en) * | 2021-09-07 | 2023-03-16 | Alexion Pharmaceuticals, Inc. | Methods of treating copper metabolism-associated diseases or disorders |
| WO2024162974A1 (en) * | 2023-01-30 | 2024-08-08 | Alexion Pharmaceuticals, Inc. | Tetrathiomolybdic acid for use in treating copper metabolism-associated diseases or disorders (wilson disease) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020006284A (es) * | 2017-12-04 | 2021-04-12 | Alexion Pharma Int Operations Unlimited Company | Tetratiomolibdato de bis-colina para tratar la enfermedad de wilson. |
| US20220334135A1 (en) | 2019-09-12 | 2022-10-20 | Alexion Pharmaceuticals, Inc. | Methods of measuring copper concentration in biological samples |
-
2021
- 2021-11-12 EP EP21824150.3A patent/EP4243806A1/en active Pending
- 2021-11-12 CA CA3172751A patent/CA3172751A1/en active Pending
- 2021-11-12 JP JP2023528431A patent/JP2023549814A/ja active Pending
- 2021-11-12 WO PCT/US2021/059239 patent/WO2022104135A1/en not_active Ceased
- 2021-11-12 US US18/036,617 patent/US20230414654A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023549814A5 (https=) | ||
| Trzil | Feline asthma: diagnostic and treatment update | |
| JP5797083B2 (ja) | 神経変性疾患の処置における亜塩素酸 | |
| Kim et al. | Neurological complications during treatment of Middle East respiratory syndrome | |
| Fagius et al. | Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trial | |
| Babakhanian et al. | Sexual dysfunction in male crystalline heroin dependents before and after MMT: A pilot study | |
| JP2021513077A5 (https=) | ||
| JP2024001208A5 (https=) | ||
| JP2020515639A5 (https=) | ||
| JP2024102078A (ja) | カルボキシマルトース第二鉄による鉄欠乏症の治療 | |
| AU2023356443A1 (en) | Protein marker for assessing and treating neurodegenerative diseases | |
| JP2024532131A5 (https=) | ||
| Lapenna et al. | Post-vaccinic opsoclonus–myoclonus syndrome: a case report | |
| Kunta et al. | The effect of anxiety and stress on acceptance of dental procedure before and after inhalation sedation in pediatric patients: an in vivo study | |
| JP2024534936A5 (https=) | ||
| JP2020518604A (ja) | Ｉｌ−１７アンタゴニストを使用して喘息を選択的に治療する方法 | |
| Couet et al. | Pharmacokinetics of quinine and doxycycline in patients with acute falciparum malaria: a study in Africa | |
| Neijens et al. | Release of histamine from leucocytes and its determinants in vitro in rotation to bronchial responsiveness to inhaled histamine and exercise in vivo | |
| Abousaeedi et al. | Viral and psychiatric disorders in methadone maintenance therapy (MMT) clients | |
| Ramachandran et al. | Allergic Bronchopulmonary Aspergillosis and Candida albicans Colonization of the Respiratory Tract in Corticosteroid· Dependent Asthma | |
| Ramachandran et al. | A Novel Maxillofacial Technology for Drug Administration-A Randomized Controlled Trial Using Metronidazole | |
| WO2011040651A1 (ja) | アトピー性皮膚炎の治療薬 | |
| Tremblay et al. | Usefulness and limitation of bioavailable testosterone in assessment of androgenicity during the process of aging in men | |
| Hollander | The Pharmacokinetics and Pharmacodynamics of Kanamycin and Capreomycin in Patients with Drug Resistant-Tuberculosis and the Relationship between Hearing Levels: A Feasibility Study | |
| Ownby et al. | Thyroid function and depression in HIV-1 infection |